First Mercantile Trust’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-829
Closed -$4K 898
2019
Q4
$4K Sell
829
-67
-7% -$416 ﹤0.01% 862
2019
Q3
$7K Sell
896
-47
-5% -$513 ﹤0.01% 900
2019
Q2
$12K Sell
943
-84
-8% -$1.19K ﹤0.01% 841
2019
Q1
$16K Sell
1,027
-44
-4% -$728 ﹤0.01% 846
2018
Q4
$21K Sell
1,071
-44
-4% -$966 0.01% 855
2018
Q3
$36K Sell
1,115
-48
-4% -$1.46K 0.01% 824
2018
Q2
$31K Buy
+1,163
New +$31.6K 0.01% 850

Other funds holding STIM

First Mercantile Trust's STIM Position: Q1 2020 in Review

First Mercantile Trust sold out of Neuronetics (STIM) in Q1 2020, closing a stake of 829 shares — an estimated $4K sold.

First Mercantile Trust first reported a position in STIM in Q2 2018 and held it in 7 quarters. The position peaked at $36K in Q3 2018. 59 funds tracked by Wall St. Rank hold STIM as of Q1 2020.

  • First Mercantile Trust reported no remaining Neuronetics position as of Q1 2020 after selling out during the quarter.
  • First Mercantile Trust sold 829 Neuronetics shares in Q1 2020, an estimated $4K.
  • First Mercantile Trust first reported a position in Neuronetics in Q2 2018 and held it in 7 quarters.
  • First Mercantile Trust's Neuronetics position peaked at $36K in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Neuronetics as of Q1 2020.

Based on First Mercantile Trust's 13F filing for Q1 2020, filed 12 May 2020.